Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $263M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 18.05.2023 | MPM Capita... | mpmcapital... |
| - | DCVC | dcvc.com/ |
| - | WRF Capita... | wrfseattle... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.06.2021 | Series B | $210M | - |
| 18.11.2020 | Series A | $53M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 04.01.2024 | IASO BIO Announces New Development Partnership with Umoja Bi... | SAN JOSE, Calif., SHANGHAI and NANJING, China, Jan. 4, 2024 /PRNewswire/ -- IASO Biotherapeutics (&q... | en.prnasia... |
| 21.11.2022 | Umoja Biopharma and IASO Biotherapeutics Announce Research C... | Collaboration will bring together Umoja's iCIL platform and IASO's chimeric antigen receptors to cre... | en.prnasia... |
| 27.07.2021 | Umoja Biopharma Expands Management Team with Key Hires in Re... | SEATTLE, July 27, 2021 /PRNewswire/ -- Umoja Biopharma, an oncology company leveraging its proprie... | prnewswire... |
| 21.06.2021 | Umoja Biopharma Raises $210M in Series B Funding | Umoja Biopharma, a Seattle, WA-based oncology company, closed a $210m Series B financing. The round... | finsmes.co... |
| 21.06.2021 | The bizarre story of Lordstown Motors | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 21.06.2021 | Umoja Biopharma Closes an Oversubscribed $210 Million Series... | - | mpmcapital... |
| 18.06.2021 | Immunotherapy startup Umoja lands $210M, less than a year af... | Umoja Biopharma CEO Andy Scharenberg. (Umoja Photo) New funding: Just seven months after announcing... | geekwire.c... |
| 15.06.2021 | Umoja Biopharma Scores $210M Series B Round | SEATTLE, WA, Umoja Biopharma today announced the completion of an oversubscribed $210 million Seri... | vcnewsdail... |
| 15.06.2021 | Umoja Biopharma Closes an Oversubscribed $210 Million Series... | SEATTLE, June 15, 2021 /PRNewswire/ -- Umoja Biopharma, an oncology company leveraging its proprie... | prnewswire... |
| 08.06.2021 | Umoja Biopharma Announces Appointment of David Fontana, Ph.D... | SEATTLE, June 8, 2021 /PRNewswire/ -- Umoja Biopharma, a leading oncology company leveraging its p... | prnewswire... |
Show more